These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 117495)

  • 21. Effects of monosialoganglioside on dopaminergic supersensitivity.
    Vital MA; Frussa-Filho R; Palermo-Neto J
    Life Sci; 1995; 56(26):2299-307. PubMed ID: 7791517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
    Carvalho RC; Fukushiro DF; Helfer DC; Callegaro-Filho D; Trombin TF; Zanlorenci LH; Sanday L; Silva RH; Frussa-Filho R
    Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subchronic treatment with haloperidol and clozapine in rats with neonatal excitotoxic hippocampal damage.
    Lipska BK; Weinberger DR
    Neuropsychopharmacology; 1994 May; 10(3):199-205. PubMed ID: 7916917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential enhancement of behavioral sensitivity to apomorphine following chronic treatment of rats with (-)-sulpiride and haloperidol.
    Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
    Eur J Pharmacol; 1982 Jun; 81(1):1-9. PubMed ID: 6889533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BehavioraL and biochemical changes caused by muscimol in mice withdrawN from haloperidol administration.
    Kuruvilla A; Fung YK; Uretsky NJ
    Neuropharmacology; 1982 Sep; 21(9):891-7. PubMed ID: 6890637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroleptic-induced emotional defecation: effects of pimozide and apomorphine.
    Sanberg PR
    Physiol Behav; 1989 Aug; 46(2):199-202. PubMed ID: 2602459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tardive dyskinesia: behavioral effects of repeated intracerebroventricular haloperidol injections in rats do not confirm the kindling hypothesis.
    Andreassen OA; Jørgensen HA
    Pharmacol Biochem Behav; 1994 Oct; 49(2):309-12. PubMed ID: 7824543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of withdrawal from long-term barbital treatment on open-field behaviour and seizure susceptibility of rats.
    Palermo-Neto J; De Lima TC
    Neuropharmacology; 1982 Mar; 21(3):277-81. PubMed ID: 6122187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat.
    Pittman KJ; Jakubovic A; Fibiger HC
    Psychopharmacology (Berl); 1984; 82(4):371-7. PubMed ID: 6427831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The interaction between beta-[Tyr9]melanotropin-(9-18), haloperidol and amphetamine in different behavior tests of rats.
    Telegdy G; Vécsei L; Schally AV; Coy DH
    Pharmacol Biochem Behav; 1982 Jul; 17(1):15-8. PubMed ID: 7122660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spontaneous activity and apomorphine stereotypy during and after withdrawal from 3 1/2 months continuous administration of haloperidol: some methodological issues.
    Waddington JL; Gamble SJ
    Psychopharmacology (Berl); 1980; 71(1):75-7. PubMed ID: 6779327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Voluntary oral morphine self-administration in rats: effect of haloperidol or ondansetron.
    Borg PJ; Taylor DA
    Pharmacol Biochem Behav; 1994 Mar; 47(3):633-46. PubMed ID: 8208784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of haloperidol withdrawal on motor activity and circadian rhythm of rats.
    Kumar A; Chandra O; Saxena PN
    Arzneimittelforschung; 1981; 31(7):1096-8. PubMed ID: 7196758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity.
    De Veaugh-Geiss J; Devanand DP; Carey RJ
    Biol Psychiatry; 1982 Nov; 17(11):1289-301. PubMed ID: 6891268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in behavioral sensitivity to SKF-38393 and quinpirole following withdrawal from continuous cocaine administration in rats.
    Neisewander JL; Lucki I; McGonigle P
    Pharmacol Biochem Behav; 1996 Apr; 53(4):935-42. PubMed ID: 8801600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The attenuation of delta 9-tetrahydrocannabinol and morphine of the quasi-morphine withdrawal syndrome in rats.
    Zaluzny SG; Chesher GB; Jackson DM; Malor R
    Psychopharmacology (Berl); 1979 Mar; 61(2):207-16. PubMed ID: 86997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haloperidol ameliorates androgen-induced behavioral deficits in developing male rats.
    Qi C; Ji X; Zhang G; Kang Y; Huang Y; Cui R; Li S; Cui H; Shi G
    J Endocrinol; 2018 May; 237(2):193-205. PubMed ID: 29563235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavioral supersensitivity to beta-phenylethylamine after chronic administration of haloperidol.
    Stoff DM; Jeste DV; Gillin JC; Moja EA; Cohen L; Stauderman KA; Wyatt RJ
    Biol Psychiatry; 1984 Jan; 19(1):101-6. PubMed ID: 6538440
    [No Abstract]   [Full Text] [Related]  

  • 39. Lithium dissociates haloperidol-induced behavioral supersensitivity from reduced dopac increase in rat striatum.
    Meller E; Friedman E
    Eur J Pharmacol; 1981 Nov; 76(1):25-9. PubMed ID: 7318921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behavioral evidence for dopamine receptor subsensitivity following chronic haloperidol.
    Lynch MR
    Neuropsychobiology; 1990-1991; 24(2):102-8. PubMed ID: 2151972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.